Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar Continuous Infusion + Chemo in Untreated Stage IIIB/IV NSCLC
NCT03706703Phase 2Unknown
- Sponsor
- Cancer Center of Guangzhou Medical University
- Start
- Oct 2018
- Primary completion
- Apr 2020
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in non-small cell lung cancer (NSCLC), sponsored by Cancer Center of Guangzhou Medical University. Status: unknown.
02
Drugs
endostar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03706703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03706703.